Clinical Trial Update: Evaluation of the Efficacy and Safety of Lactobacillus Crispatus M247 (Crispact®) With Vaginal Laser Therapy in Menopausal Women With Atrophic Vulvovaginitis (VVA) [NA]

View source ↗

Summary

A completed clinical trial assessed the efficacy and safety of the probiotic Lactobacillus crispatus M247 (Crispact) used in combination with vaginal laser ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Vulvovaginitis

Drugs mentioned

• Crispact (Lactobacillus crispatus M247)

Snippet

Sponsor: Liaquat University of Medical & Health Sciences | Conditions: Atrophic Vulvovaginitis | NA | Status: COMPLETED